There was no statistically significant difference in age, sex, smoking and diabetes history, baseline CA199 level, CEA level, NLR, weight loss, lymph node metastasis, and postoperative adjuvant chemotherapy between PHC and PBTC subgroups (P>0.05). This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.